But in BLCA, GATA3 was negatively correlated with most immunomodulators, including immunomostimulators (such as TNF, ULBP1, and CD276), MHC (such as HLA), receptors, and chemokines (Figure 2A). This evidence concerns the gene HLA-C and bladder transitional cell carcinoma.